LIFECORE BIOMEDICAL, INC. Increase (Decrease) in Inventories
LIFECORE BIOMEDICAL, INC. (LFCR) reported Increase (Decrease) in Inventories of -$3.61 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInInventories · last filed 2026-08-05
- LIFECORE BIOMEDICAL, INC. increase (decrease) in inventories for the quarter ending 2026-06-30 was -$2.68M.
- LIFECORE BIOMEDICAL, INC. increase (decrease) in inventories for the quarter ending 2026-03-31 was -$930.00K.
- LIFECORE BIOMEDICAL, INC. increase (decrease) in inventories for the quarter ending 2025-09-30 was -$1.97M.
- LIFECORE BIOMEDICAL, INC. increase (decrease) in inventories for the quarter ending 2025-05-25 was -$2.30M, a 845.63% decline year-over-year.
- LIFECORE BIOMEDICAL, INC. increase (decrease) in inventories for fiscal 2025 was -$7.69M.
- LIFECORE BIOMEDICAL, INC. increase (decrease) in inventories for fiscal 2024 was -$862.00K, a 105.82% decline from fiscal 2023.
- LIFECORE BIOMEDICAL, INC. increase (decrease) in inventories for fiscal 2023 was $14.81M, a 579.40% increase from fiscal 2022.
- LIFECORE BIOMEDICAL, INC. increase (decrease) in inventories for fiscal 2022 was $2.18M, a 22.67% decline from fiscal 2021.
| Period end | Increase (Decrease) in Inventories 3 month | Increase (Decrease) in Inventories 3 month as first filed | Increase (Decrease) in Inventories 6 month | Increase (Decrease) in Inventories 6 month as first filed | Increase (Decrease) in Inventories 7 month | Increase (Decrease) in Inventories 9 month | Increase (Decrease) in Inventories 9 month as first filed | Increase (Decrease) in Inventories 12 month | Increase (Decrease) in Inventories 12 month as first filed |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$2.68M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | -$3.61M 10-Q · filed 2026-08-05 | |||||||
| 2026-03-31 | -$930.00K 10-Q · filed 2026-05-06 | ||||||||
| 2025-12-31 | -$3.21M 10-KT · filed 2026-03-16 | ||||||||
| 2025-09-30 | -$1.97M 10-Q · filed 2025-11-06 | ||||||||
| 2025-05-25 | -$2.30M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | -$6.92M 10-Q · filed 2026-08-05 | -$9.35M derived: sum of 3 quarters · filed 2026-08-05 | -$7.69M 10-KT · filed 2026-03-16 | |||||
| 2025-02-23 | -$4.62M 10-Q · filed 2026-05-06 | -$7.05M derived: sum of 2 quarters · filed 2026-05-06 | -$5.38M 10-Q · filed 2025-04-03 | -$5.08M derived: sum of 4 quarters · filed 2026-05-06 | |||||
| 2024-11-24 | -$2.43M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-01-02 | -$765.00K 10-Q · filed 2025-01-02 | -$456.00K derived: sum of 3 quarters · filed 2026-03-16 | -$2.23M derived: sum of 4 quarters · filed 2026-03-16 | |||||
| 2024-08-25 | $1.66M 10-Q · filed 2025-11-06 | $1.97M derived: sum of 2 quarters · filed 2026-03-16 | $196.00K derived: sum of 3 quarters · filed 2026-03-16 | -$48.00K derived: sum of 4 quarters · filed 2026-03-16 | |||||
| 2024-05-26 | $309.00K derived: 10-KT 12 month − 10-Q 9 month · filed 2026-03-16 | -$1.47M derived: sum of 2 quarters · filed 2026-03-16 | -$1.71M derived: sum of 3 quarters · filed 2026-03-16 | -$862.00K 10-KT · filed 2026-03-16 | |||||
| 2024-02-25 | -$1.78M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-04-03 | -$2.02M derived: sum of 2 quarters · filed 2025-04-03 | -$1.17M 10-Q · filed 2025-04-03 | -$1.21M derived: sum of 4 quarters · filed 2025-04-03 | |||||
| 2023-11-26 | -$244.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-01-02 | $605.00K 10-Q · filed 2025-01-02 | $569.00K derived: sum of 3 quarters · filed 2025-01-02 | $5.84M derived: sum of 4 quarters · filed 2025-01-02 | |||||
| 2023-08-27 | $849.00K 10-Q · filed 2024-10-04 | $813.00K derived: sum of 2 quarters · filed 2024-10-04 | $6.08M derived: sum of 3 quarters · filed 2024-10-04 | $18.25M derived: sum of 4 quarters · filed 2024-10-04 | |||||
| 2023-05-28 | -$36.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-08-26 | $5.24M derived: sum of 2 quarters · filed 2024-08-26 | $17.40M derived: sum of 3 quarters · filed 2024-08-26 | $14.81M 10-K · filed 2024-08-26 | |||||
| 2023-02-26 | $5.27M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-08-09 | $17.43M derived: sum of 2 quarters · filed 2024-08-09 | $14.85M 10-Q · filed 2024-08-09 | $13.45M 10-Q · filed 2023-06-02 | $6.66M derived: sum of 4 quarters · filed 2024-08-26 | ||||
| 2022-11-27 | $12.16M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-09 | $9.58M 10-Q · filed 2024-08-09 | $10.68M 10-Q · filed 2023-03-16 | $1.38M derived: sum of 3 quarters · filed 2024-08-26 | $2.76M derived: sum of 4 quarters · filed 2024-08-26 | ||||
| 2022-08-28 | -$2.59M 10-Q · filed 2024-08-09 | -$2.56M 10-Q · filed 2022-10-07 | -$10.78M derived: sum of 2 quarters · filed 2024-08-26 | -$9.41M derived: sum of 3 quarters · filed 2024-08-26 | $138.00K derived: sum of 4 quarters · filed 2024-08-26 | ||||
| 2022-05-29 | -$8.19M derived: 10-K 12 month − 10-K 9 month · filed 2024-08-26 | -$6.82M derived: sum of 2 quarters · filed 2024-08-26 | $2.73M derived: sum of 3 quarters · filed 2024-08-26 | $2.18M 10-K · filed 2024-08-26 | $5.96M 10-K · filed 2022-09-14 | ||||
| 2022-02-27 | $1.37M derived: 10-K 9 month − 10-K 6 month · filed 2024-03-20 | $10.92M derived: sum of 2 quarters · filed 2024-03-20 | $10.37M 10-K · filed 2024-03-20 | $11.91M 10-Q · filed 2022-04-07 | $3.68M derived: sum of 4 quarters · filed 2024-03-20 | ||||
| 2021-11-28 | $9.54M derived: 10-K 6 month − 10-K 3 month · filed 2024-03-20 | $9.00M 10-K · filed 2024-03-20 | $9.77M 10-Q · filed 2022-01-07 | $2.30M derived: sum of 3 quarters · filed 2024-03-20 | $6.93M derived: sum of 4 quarters · filed 2024-03-20 | ||||
| 2021-08-29 | -$545.00K 10-K · filed 2024-03-20 | -$248.00K 10-Q · filed 2021-10-05 | -$7.24M derived: sum of 2 quarters · filed 2024-03-20 | -$2.62M derived: sum of 3 quarters · filed 2024-03-20 | $8.69M derived: sum of 4 quarters · filed 2024-03-20 | ||||
| 2021-05-30 | -$6.70M derived: 10-K 12 month − 10-K 9 month · filed 2024-03-20 | -$2.07M derived: sum of 2 quarters · filed 2024-03-20 | $9.23M derived: sum of 3 quarters · filed 2024-03-20 | $2.82M 10-K · filed 2024-03-20 | $3.35M 10-K · filed 2021-07-29 | ||||
| 2021-02-28 | $4.62M derived: 10-K 9 month − 10-Q 6 month · filed 2024-03-20 | $15.93M derived: sum of 2 quarters · filed 2024-03-20 | $9.52M 10-K · filed 2024-03-20 | $10.47M 10-Q · filed 2021-04-08 | $8.77M derived: sum of 4 quarters · filed 2024-03-20 | ||||
| 2020-11-29 | $11.30M derived: 10-Q 6 month − 10-K 3 month · filed 2022-01-07 | $4.89M 10-Q · filed 2022-01-07 | $4.14M derived: sum of 3 quarters · filed 2024-03-20 | $12.64M derived: sum of 4 quarters · filed 2024-03-20 | |||||
| 2020-08-30 | -$6.41M 10-K · filed 2024-03-20 | -$6.31M 10-Q · filed 2020-10-07 | -$7.16M derived: sum of 2 quarters · filed 2024-03-20 | $1.33M derived: sum of 3 quarters · filed 2024-03-20 | $4.88M derived: sum of 4 quarters · filed 2024-03-20 | ||||
| 2020-05-31 | -$748.00K derived: 10-K/A 12 month − 10-Q 9 month · filed 2023-03-16 | $7.75M derived: sum of 2 quarters · filed 2023-03-16 | $11.29M derived: sum of 3 quarters · filed 2023-03-16 | $12.18M 10-K/A · filed 2023-03-16 | |||||
| 2020-02-23 | $8.50M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-04-08 | $12.04M derived: sum of 2 quarters · filed 2021-04-08 | $12.93M 10-Q · filed 2021-04-08 | $22.83M derived: sum of 4 quarters · filed 2021-07-29 | |||||
| 2019-11-24 | $3.54M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-01-07 | $4.43M 10-Q · filed 2021-01-07 | $14.34M derived: sum of 3 quarters · filed 2021-07-29 | $15.55M derived: sum of 4 quarters · filed 2021-07-29 | |||||
| 2019-08-25 | $888.00K 10-Q · filed 2020-10-07 | $10.79M derived: sum of 2 quarters · filed 2021-07-29 | $12.01M derived: sum of 3 quarters · filed 2021-07-29 | $13.65M derived: sum of 4 quarters · filed 2021-07-29 | |||||
| 2019-05-26 | $9.90M derived: 10-K 12 month − 10-Q 9 month · filed 2021-07-29 | $11.12M derived: sum of 2 quarters · filed 2021-07-29 | $12.76M derived: sum of 3 quarters · filed 2021-07-29 | $10.93M 10-K · filed 2021-07-29 | |||||
| 2019-02-24 | $1.22M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-04-03 | $2.86M derived: sum of 2 quarters · filed 2020-04-03 | $1.02M 10-Q · filed 2020-04-03 | $4.09M derived: sum of 4 quarters · filed 2020-08-14 | |||||
| 2018-11-25 | $1.64M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-01-02 | -$191.00K 10-Q · filed 2020-01-02 | $2.88M derived: sum of 3 quarters · filed 2020-08-14 | $792.00K derived: sum of 4 quarters · filed 2020-08-14 | |||||
| 2018-08-26 | -$1.83M 10-Q · filed 2019-10-03 | $1.24M derived: sum of 2 quarters · filed 2020-08-14 | -$850.00K derived: sum of 3 quarters · filed 2020-08-14 | $1.85M derived: sum of 4 quarters · filed 2020-08-14 | |||||
| 2018-05-27 | $3.07M derived: 10-K 12 month − 10-Q 9 month · filed 2020-08-14 | $983.00K derived: sum of 2 quarters · filed 2020-08-14 | $3.68M derived: sum of 3 quarters · filed 2020-08-14 | $6.53M 10-K · filed 2020-08-14 | |||||
| 2018-02-25 | -$2.09M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-04-04 | $610.00K derived: sum of 2 quarters · filed 2019-04-04 | $3.46M 10-Q · filed 2019-04-04 | $4.87M derived: sum of 4 quarters · filed 2019-08-01 | |||||
| 2017-11-26 | $2.70M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-01-07 | $5.55M 10-Q · filed 2019-01-07 | $6.95M derived: sum of 3 quarters · filed 2019-08-01 | $2.26M derived: sum of 4 quarters · filed 2019-08-01 | |||||
| 2017-08-27 | $2.85M 10-Q · filed 2018-10-05 | $4.26M derived: sum of 2 quarters · filed 2019-08-01 | -$441.00K derived: sum of 3 quarters · filed 2019-08-01 | -$2.65M derived: sum of 4 quarters · filed 2019-08-01 | |||||
| 2017-05-28 | $1.41M derived: 10-K 12 month − 10-Q 9 month · filed 2019-08-01 | -$3.29M derived: sum of 2 quarters · filed 2019-08-01 | -$5.50M derived: sum of 3 quarters · filed 2019-08-01 | -$855.00K 10-K · filed 2019-08-01 | |||||
| 2017-02-26 | -$4.70M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-04-05 | -$6.91M derived: sum of 2 quarters · filed 2018-04-05 | -$2.26M 10-Q · filed 2018-04-05 | -$3.89M derived: sum of 4 quarters · filed 2018-08-09 | |||||
| 2016-11-27 | -$2.21M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-01-05 | $2.44M 10-Q · filed 2018-01-05 | $808.00K derived: sum of 3 quarters · filed 2018-08-09 | -$889.00K derived: sum of 4 quarters · filed 2018-08-09 | |||||
| 2016-08-28 | $4.65M 10-Q · filed 2017-09-28 | $3.02M derived: sum of 2 quarters · filed 2018-08-09 | $1.32M derived: sum of 3 quarters · filed 2018-08-09 | $1.76M derived: sum of 4 quarters · filed 2018-08-09 | |||||
| 2016-05-29 | -$1.63M derived: 10-K 12 month − 10-Q 9 month · filed 2018-08-09 | -$3.32M derived: sum of 2 quarters · filed 2018-08-09 | -$2.89M derived: sum of 3 quarters · filed 2018-08-09 | $508.00K 10-K · filed 2018-08-09 | |||||
| 2016-02-28 | -$1.70M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-04-07 | -$1.26M derived: sum of 2 quarters · filed 2017-04-07 | $2.13M 10-Q · filed 2017-04-07 | $2.50M derived: sum of 4 quarters · filed 2018-03-15 | |||||
| 2015-11-29 | $436.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-01-05 | $3.83M 10-Q · filed 2017-01-05 | $4.20M derived: sum of 3 quarters · filed 2018-03-15 | -$1.58M derived: sum of 4 quarters · filed 2018-03-15 | |||||
| 2015-08-30 | $3.40M 10-Q · filed 2016-09-29 | $3.76M derived: sum of 2 quarters · filed 2018-03-15 | -$2.02M derived: sum of 3 quarters · filed 2018-03-15 | $589.00K derived: sum of 4 quarters · filed 2018-03-15 | |||||
| 2015-05-31 | $365.00K derived: 10-K/A 12 month − 10-Q 9 month · filed 2018-03-15 | -$5.41M derived: sum of 2 quarters · filed 2018-03-15 | -$2.81M derived: sum of 3 quarters · filed 2018-03-15 | $292.00K 10-K/A · filed 2018-03-15 | |||||
| 2015-03-01 | -$5.78M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-03-30 | -$3.17M derived: sum of 2 quarters · filed 2016-03-30 | -$73.00K 10-Q · filed 2016-03-30 | -$1.01M derived: sum of 4 quarters · filed 2016-08-01 | |||||
| 2014-11-30 | $2.61M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-01-07 | $5.71M 10-Q · filed 2016-01-07 | $4.77M derived: sum of 3 quarters · filed 2016-08-01 | $3.58M derived: sum of 4 quarters · filed 2016-08-01 | |||||
| 2014-08-31 | $3.10M 10-Q · filed 2015-10-01 | $2.17M derived: sum of 2 quarters · filed 2016-08-01 | $969.00K derived: sum of 3 quarters · filed 2016-08-01 | $3.25M derived: sum of 4 quarters · filed 2016-08-01 | |||||
| 2014-05-25 | -$933.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-08-01 | -$2.13M derived: sum of 2 quarters · filed 2016-08-01 | $146.00K derived: sum of 3 quarters · filed 2016-08-01 | $622.00K 10-K · filed 2016-08-01 | |||||
| 2014-02-23 | -$1.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-04-02 | $1.08M derived: sum of 2 quarters · filed 2015-04-02 | $1.55M 10-Q · filed 2015-04-02 | $3.28M derived: sum of 4 quarters · filed 2015-07-31 | |||||
| 2013-11-24 | $2.28M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-01-09 | $2.75M 10-Q · filed 2015-01-09 | $4.48M derived: sum of 3 quarters · filed 2015-07-31 | $2.46M derived: sum of 4 quarters · filed 2015-07-31 | |||||
| 2013-08-25 | $476.00K 10-Q · filed 2014-10-08 | $2.20M derived: sum of 2 quarters · filed 2015-07-31 | $187.00K derived: sum of 3 quarters · filed 2015-07-31 | $1.05M derived: sum of 4 quarters · filed 2015-07-31 | |||||
| 2013-05-26 | $1.73M derived: 10-K 12 month − 10-Q 9 month · filed 2015-07-31 | -$289.00K derived: sum of 2 quarters · filed 2015-07-31 | $570.00K derived: sum of 3 quarters · filed 2015-07-31 | $2.10M 10-K · filed 2015-07-31 | |||||
| 2013-02-24 | -$2.02M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-03-28 | -$1.16M derived: sum of 2 quarters · filed 2014-03-28 | $374.00K 10-Q · filed 2014-03-28 | $1.04M derived: sum of 4 quarters · filed 2014-08-01 | |||||
| 2012-11-25 | $859.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-01-03 | $2.39M 10-Q · filed 2014-01-03 | $3.06M derived: sum of 3 quarters · filed 2014-08-01 | $2.82M derived: sum of 4 quarters · filed 2014-08-01 | |||||
| 2012-08-26 | $1.53M 10-Q · filed 2013-09-26 | -$1.53M 10-Q · filed 2012-10-03 | $2.20M derived: sum of 2 quarters · filed 2014-08-01 | $1.96M derived: sum of 3 quarters · filed 2014-08-01 | $2.51M derived: sum of 4 quarters · filed 2014-08-01 | ||||
| 2012-05-27 | $670.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-08-01 | $427.00K derived: sum of 2 quarters · filed 2014-08-01 | $974.00K derived: sum of 3 quarters · filed 2014-08-01 | $441.00K 10-K · filed 2014-08-01 | -$441.00K 10-K · filed 2012-08-08 | ||||
| 2012-02-26 | -$243.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-04-04 | $304.00K derived: sum of 2 quarters · filed 2013-04-04 | -$229.00K 10-Q · filed 2013-04-04 | $229.00K 10-Q · filed 2012-03-28 | $6.65M derived: sum of 4 quarters · filed 2013-08-07 | ||||
| 2011-11-27 | $547.00K derived: 10-Q 6 month − 10-Q/A 3 month · filed 2013-01-04 | $14.00K 10-Q · filed 2013-01-04 | -$14.00K 10-Q · filed 2012-01-05 | $6.89M derived: sum of 3 quarters · filed 2013-08-07 | |||||
| 2011-08-28 | -$533.00K 10-Q/A · filed 2013-01-02 | $533.00K 10-Q · filed 2011-10-05 | $6.35M derived: sum of 2 quarters · filed 2013-08-07 | ||||||
| 2011-05-29 | $6.88M derived: 10-K 12 month − 10-Q 9 month · filed 2013-08-07 | $4.05M 10-K · filed 2013-08-07 | -$4.05M 10-K · filed 2012-08-08 | ||||||
| 2011-02-27 | -$2.83M 10-Q · filed 2012-03-28 | ||||||||
| 2010-11-28 | -$3.64M 10-Q · filed 2012-01-05 | ||||||||
| 2010-08-29 | -$1.96M 10-Q · filed 2011-10-05 | ||||||||
| 2010-05-30 | -$1.27M 10-K · filed 2012-08-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 | |
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B |